ClinicalTrials.gg
CompletedNCT03260959Updated Apr 10, 2018

Experience of the Father Following the Announcement of a First Pregnancy

An observational study in Family Relations and Behavior, sponsored by Hospices Civils de Lyon. Completed at 5 sites in France. Open to male participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-10.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
45
Ages
18 Years to 49 Years
Sex
Male
01

Study summary

Experience of the father following the announcement of a first pregnancy Its context, immediate reactions and actions. Possible impact of this moment of life a few months or years later?

02

Conditions studied

  • Family Relations
  • Behavior

Browse trials for

03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's enrollment of 45 is below the median of 235 across 341 observational studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Male having been the father of at least one pregnancy whatever the outcome (pregnancy pursued, or abortion)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male having been the father of at least one pregnancy whatever the outcome (pregnancy pursued, or abortion)

Exclusion criteria

Exclusion Criteria:

  • Patients with severe or neurological psychiatric disorders inducing significant cognitive impairment
  • Patients who do not master the French language
  • Patients who cannot give free and (guardianship, curatorship, safeguard of justice ...)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
45 participants (actual)
Patient registry
No

Groups and cohorts

  • Father

    Male having been the father of at least one pregnancy whatever the outcome (pregnancy pursued, or abortion)

    Behavioral: Interview by hierarchical evocation's Method

Interventions

  • BehavioralInterview by hierarchical evocation's Method

    Interview to describe the experience of the man during the announcement of a pregnancy that it is expected or not.

06

What researchers measure

Primary outcomes

  1. Interview by hierarchical evocation's method

    Experience of the man during the announcement of a pregnancy that it is expected or not, without identification of an average answer, but description of the diversity of situations, contexts, felt, taken of decision and actions. Since this study is observational and descriptive, it does not have a primary judgment criterion, the aim being to describe the studied population. However, according to the method of hierarchical evocation, it can be said that the average frequency of occurrence of the words and their average polarity index will be some outcome measure.

    Time frame: 30-45 minutes

07

Study locations

5 sites
  • Cabinet de médecine générale
    Beynost, 01700, France
  • Cabinet de médecine générale
    Crémieu, 38460, France
  • Cabinet de médecine générale
    Lyon, 69008, France
  • Cabinet de médecine générale
    Vallon-Pont-d'Arc, 07150, France
  • Cabinet de médecine générale
    Vaugneray, 69670, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2017 to primary completion in Nov 2017, 4 months.

Of 113 non-industry observational studies under Behavior, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 57. This study's 4 months is below that.

Counting every sponsor, half of 119 studies reached it within 17 months; a quarter within 6 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2017
First posted
Aug 24, 2017
StartActual
Jul 10, 2017
Primary completionActual
Nov 10, 2017
CompletionActual
Nov 10, 2017
Last update
Apr 10, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 10, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03260959
Responsible party
Sponsor
First posted
Aug 24, 2017
Start date
Jul 10, 2017
Primary completion
Nov 10, 2017
Completion
Nov 10, 2017
Last update
Apr 10, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion